| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0046 | 0.9 |